Kyte JA, Andresen NK, Russnes HG, Fretland SØ, Falk RS, Lingjærde OC, Naume B(2020) ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer J Transl Med, 18(1), 269 DOI 10.1186/s12967-020-02421-w, PubMed 32620163
Russnes HG(2020) Clinical trials in the era of precision cancer medicine - for the few or for the many? Acta Oncol, 59(7), 731-732 DOI 10.1080/0284186X.2020.1777582, PubMed 32579040
von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O(2020) Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer Int J Cancer, 147(9), 2515-2525 DOI 10.1002/ijc.33108, PubMed 32488909